Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

4.00
Delayed Data
As of Aug 04
 -0.01 / -0.25%
Today’s Change
1.76
Today|||52-Week Range
4.67
+23.08%
Year-to-Date

Today’s Trading

Previous close4.01
Today’s open4.02
Day’s range4.00 - 4.08
Volume1,437,572
Average volume (3 months)2,240,636
Market cap$640.3M
Dividend yield--
Data as of 08/04/2015

Growth & Valuation

Earnings growth (last year)+23.33%
Earnings growth (this year)+101.45%
Earnings growth (next 5 years)--
Revenue growth (last year)-10.13%
P/E ratioNM
Price/Sales432.79
Price/Book4.88

Competitors

 Today’s
change
Today’s
% change
ALRPRBAlere Inc+12.00+3.58%
QDELQuidel Corp+0.23+1.12%
VIVOMeridian Bioscience ...+0.13+0.71%
TRIBTrinity Biotech PLC-0.15-0.84%
Data as of 08/04/2015

Financials

Last reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$1.2M
Annual profit (last year)-$35.7M
Net profit margin-3,093.67%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts